From January 1, 2024 to March 31, 2024, the company has repurchased 10,300,000 shares, representing 0.5% for $1,000 million. With this, the company has completed the repurchase of 53,857,720 shares, representing 2.6% for $5,355.51 million under the buyback announced on July 18, 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
93.17 CHF | +2.13% | +0.43% | +9.78% |
08:19pm | NOVARTIS AG : UBS reiterates its Buy rating | ZD |
07:31pm | European Equities Close Higher in Friday Trading; Flash Euro Area Inflation Rises More Than Expected | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+9.78% | 21TCr | |
+39.37% | 73TCr | |
+32.83% | 59TCr | |
-6.31% | 35TCr | |
+14.77% | 32TCr | |
+2.27% | 28TCr | |
+15.00% | 24TCr | |
-5.52% | 20TCr | |
+5.37% | 16TCr | |
-1.09% | 16TCr |
- Stock Market
- Equities
- NOVN Stock
- News Novartis AG
- Tranche Update on Novartis AG's Equity Buyback Plan announced on July 18, 2023.